Correlation of Serum and Synovial Osteocalcin, Osteoprotegerin and Tumor Necrosis Factor-Alpha with the Disease Severity Score in Knee Osteoarthritis

1. Garnero P, Piperno M, Gineyts E, et al. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis. 2001;60:619-626.10.1136/ard.60.6.619Search in Google Scholar

2. Stannus O, Jones G, Cicuttini F, et al. Circulating levels of IL-6 and TNF-a are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthritis and Cartilage. 2010;18:1441-1447.10.1016/j.joca.2010.08.016Search in Google Scholar

3. Pelletier JP, Pelletier JM, Alaaeddine N. Cytokines And Their Role In The Pathophysiology Of Osteoarthritis. Frontiers in Bioscience. 1999;4:694-703.10.2741/MartelSearch in Google Scholar

4. Funck-Brentano T, Cohen-Solal M. Crosstalk between cartilage and bone: When bone cytokines matter. Cytokine & Growth Factor Reviews. 2011;22:91-97.10.1016/j.cytogfr.2011.04.003Search in Google Scholar

5. Pullig O, Weseloh G, Ronneberger D, Käkönen S, Swoboda B. Chondrocyte differentiation in human osteoarthritis: expression of osteocalcin in normal and osteoarthritic cartilage and bone. Calcif Tissue Int. 2000;67:230-40.10.1007/s002230001108Search in Google Scholar

6. Kenanidis EI, Potoupnis ME, Papavasiliou KA, et al. The serum levels of Receptor Activator of Nuclear Factor-кB Ligand, bone-specific alkaline phosphatase, osteocalcin and osteoprotegerin do not correlate with the radiographically assessed severity of idiopathic hip and knee osteoarthritis. Clinical Biochemistry. 2011;44:203-207.10.1016/j.clinbiochem.2010.09.029Search in Google Scholar

7. Salisbury C, Sharif M. Relations between synovial fluid and serum concentrations of osteocalcin and other markers of joint tissue turnover in the knee joint compared with peripheral blood. Annals of the Rheumatic Diseases. 1997;56:558-561.10.1136/ard.56.9.558Search in Google Scholar

8. Pilichou A, Papassotiriou I, Michalakakou K, et al. High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-кB ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis. Clinical Biochemistry. 2008;41:746-749.10.1016/j.clinbiochem.2008.02.011Search in Google Scholar

9. Pantsulaia I, Kalichman L, Kobyliansky E. Association between radiographic hand osteoarthritis and RANKL, OPG and inflammatory markers. Osteoarthritis and Cartilage. 2010;18:1448-1453.10.1016/j.joca.2010.06.009Search in Google Scholar

10. Castañeda S, Roman-Blas JA, Largo R. Subchondral bone as a key target for osteoarthritis treatment. Biochemical Pharmacology. 2012;83:315-323.10.1016/j.bcp.2011.09.018Search in Google Scholar

11. Collins NJ, Misra D, Felson DT, Crossley KM, Roos EM. Measures of Knee Function. Arthritis Care & Research. 2011;63:S208-S228.10.1002/acr.20632Search in Google Scholar

12. Irrgang JJ, Anderson AF, Boland AL, et al. Development and validation of the International Knee Documentation Committee subjective knee form. Am J Sports Med. 2001;29:600-613.10.1177/03635465010290051301Search in Google Scholar